查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363362

阿片类药物市场规模、份额和趋势分析报告：按产品、按用途、按给药途径、按配销通路、按地区和细分趋势，2023-2030

Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), Application (Pain Relief, Anesthesia), Route Of Administration, Distribution Channel, Region, & Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

阿片类药物市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球阿片类药物市场规模预计将达到253亿美元，预测期内年复合成长率为1.4%。

支持性法规政策正在帮助製造商推出有潜力促进市场成长的产品。例如，2021年6月，美国FDA核准了Purdue Pharma LP开发的盐酸纳美芬注射。纳美芬注射是一种鸦片拮抗，旨在逆转鸦片类药物过量摄取。该产品的核准预计将推动成长。

此外，2021 年 6 月，硫酸吗啡锭剂和硫酸吗啡口服液获得 FDA核准，用于治疗几乎没有其他治疗选择的儿童和成人患者的严重疼痛。因此，新的鸦片类药物的核准及其推出也有望推动成长。

越来越多地使用鸦片类药物来控製手术后疼痛也有望推动市场成长。根据加拿大药物使用和成瘾中心的数据，2020 年约有 11.8% 的人口使用鸦片类止痛药来控制症状。在该地区，曲马多和可待因经常作为术后阿片类药物处方。

由于用于疼痛管理的阿片类药物的非成瘾替代品的出现，阿片类药物市场的成长正在下降。据美国麻醉医师协会称，有几种非类固醇消炎剂，如阿斯匹灵、乙酰胺酚和对乙酰氨基酚。此外，与这些药物相关的广泛可得性和低成本正在导致预测期内此类产品的需求增加。例如，阿斯匹灵每包 30 片的售价为 10 美元。

此外，2022 年 2 月，美国FDA 根据 HHS 急性和慢性疼痛管理过量摄取预防策略发起了一项倡议，鼓励开发非成瘾性止痛药来取代鸦片类药物。 FDA 鼓励製药公司开发非鸦片类止痛药。这些配合措施可能会限制阿片类药物市场的整体成长。

阿片类药物市场报告亮点

  • 按产品划分，由于新的缓释/长效阿片领域药物的核准和上市数量增加，缓释/长效阿片类药物细分市场在 2022 年占据了最大的市场占有率。例如，2021年6月，美国FDA接受了丁丙诺啡（Brixadi）用于疼痛管理的新药认证申请。丁丙诺啡是一种缓释性、长效的鸦片类药物。
  • 从用途来看，预计2022年止痛领域将主导鸦片类药物市场，由于慢性疼痛患者的增加，预计市场将显着成长。根据加拿大健康资讯研究所和加拿大疼痛工作小组 2021 年的报告，加拿大有五分之一的成年人患有慢性疼痛。
  • 从给药途径来看，注射剂在 2022 年占据鸦片类药物市场的主导地位。这一优点是由于用于治疗慢性疼痛的产品的广泛使用以及需要麻醉的手术数量的增加。
  • 从配销通路来看，2022年阿片类药物市场零售药局占据主导地位。该领域的成长是由阿片类药物配药率较高的零售药局的存在所推动的。
  • 预计亚太地区在预测期内成长最快。该地区的增长是由于人口老化的增加，而老龄化人口更容易罹患。

目录

第1章调查方法和范围

第2章执行摘要

第3章阿片类药物市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 阿片类药物市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章阿片类药物：按产品分类的估算与趋势分析

  • 阿片类药物市场：要点
  • 阿片类药物市场：2022 年和 2030 年趋势和市场占有率分析
  • 红外线/短效阿片类药物
  • ER/长效型鸦片类药物

第5章阿片类药物：依用途估算与趋势分析

  • 阿片类药物市场：要点
  • 阿片类药物市场：2022 年和 2030 年趋势和市场占有率分析
  • 止痛药
  • 麻醉
  • 止咳药
  • 抑制腹泻
  • 戒成瘾

第6章阿片类药物：按给药途径的估计和趋势分析

  • 阿片类药物市场：要点
  • 阿片类药物市场：2022 年和 2030 年趋势和市场占有率分析
  • 口服
  • 注射
  • 其他的

第7章阿片类药物：按配销通路的估计和趋势分析

  • 阿片类药物市场：要点
  • 阿片类药物市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院药房
  • 零售药房
  • 其他的

第8章阿片类药物市场：区域估计和趋势分析

  • 区域展望
  • 按地区分類的鸦片类药物市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第9章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Purdue Pharma LP
    • Johnson & Johnson Services, Inc.
    • Hikma Pharmaceuticals PLC
    • Pfizer Inc.
    • AbbVie Inc.
    • Sanofi
    • Sun Pharmaceutical Industries Ltd
    • Grunenthal
    • Merck & Co., Inc.
Product Code: GVR-2-68038-131-3

Opioids Market Growth & Trends:

The global opioid market size is expected to reach USD 25.3 billion by 2030, registering a CAGR of 1.4% during the forecast period, according to a new report by Grand View Research, Inc.. Supportive regulatory policies aid manufacturers to introduce products that may contribute to the market growth. For instance, in June 2021, the U.S. FDA approved nalmefene hydrochloride injection developed by Purdue Pharma L.P.Nalmefene injectable is an opioid antagonist designed to reverse opioid overdose. The expected approval of a product is anticipated to drive the growth.

Moreover, in June 2021, morphine sulfate tablets and morphine sulfate oral solution were approved by FDA for the management of severe pain in pediatric and adult patients for whom other treatment options were less. Thus, approval of new opioid and their launch is also expected to drive the growth.

Growing use of the opioids for the management of post-operative pain, caused due to the surgeries, is expected to drive the market growth. According to the Canadian Centre on Substance Use and Addiction, in 2020, approximately 11.8% of all the population used opioid analgesics for the management of symptoms. Tramadol and codeine are frequently dispensed for the postoperative opioid prescription in surgeries within the region.

Emergence of non-addictive alternative products to opioids for the pain-management leads to decline in the growth of opioid market. According to American Society of Anesthesiologists, there are several non-opioid medicines that are available over the counter steroids and NSAIDs such as aspirin, ibuprofen, and acetaminophen among others. Furthermore, wide availability and low cost associated with these drugs contribute to increase in demand for such products during the forecast period. For instance, aspirin cost USD 10 for a pack of 30 tablets.

In addition, in February 2022, the U.S. FDA has undertaken an initiative to encourage the development of non-addictive analgesics alternatives to opioids under its HHS overdose prevention strategy for the management of acute and chronic pain. The regulatory agency issued recommendation to pharmaceutical companies to develop non-opioid analgesic products. Such initiatives may restrain the overall growth of the opioids market.

Opioids Market Report Highlights:

  • By product, ER/long acting opioids segment held the largest market share in 2022 due to the increasing approval and launch of the novel ER/ long-acting opioids. For instance, in June 2021, the U.S. FDA accepted a review application for a new drug application for buprenorphine (Brixadi) for the pain management. Buprenorphine is an extended release long-acting opioid drug
  • By application, pain relief segment dominated the opioids market in 2022 and is expected to witness significant market growth owing to increasing prevalence of the patients with chronic pain. According to the Canadian Institute for Health Information and Canadian Pain Task Force report of 2021, 1 in every 5 adults in Canada suffers from chronic pain
  • By route of administration, injectable segment dominated the opioids market in 2022. This dominance can be attributed to wide availability of products used for the treatment of chronic pain and increased procedures requiring anesthesia
  • By distribution channel, retail pharmacy dominated the opioids market in 2022. The availability of retail pharmacies with high dispensing rate of opioid driving segment growth
  • Asia pacific is expected to be the fastest growing region during the forecast period. The growth of the region can be attributed to increasing geriatric population which are susceptible to the chronic pain.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Route of administration
    • 1.1.4. Distribution channel
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Route of administration outlook
    • 2.2.4. Distribution channel outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Opioids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Opioids Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Opioids: Product Estimates & Trend Analysis

  • 4.1. Opioids Market: Key Takeaways
  • 4.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. IR/Short Acting Opioids
    • 4.3.1. IR/ Short Acting Opioids market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. ER/Long Acting Opioids
    • 4.4.1. ER/ Long Acting Opioids market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Opioids: Application Estimates & Trend Analysis

  • 5.1. Opioids Market: Key Takeaways
  • 5.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pain Relief
    • 5.3.1. Pain relief market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Anesthesia
    • 5.4.1. Anesthesia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Cough Suppression
    • 5.5.1. Cough suppression market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Diarrhea Suppression
    • 5.6.1. Diarrhea suppression market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. De-addiction
    • 5.7.1. De-addiction market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Opioids: Route of Administration Estimates & Trend Analysis

  • 6.1. Opioids Market: Key Takeaways
  • 6.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Oral
    • 6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Injectable
    • 6.4.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Opioids: Distribution Channel Estimates & Trend Analysis

  • 7.1. Opioids Market: Key Takeaways
  • 7.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Hospital Pharmacy
    • 7.3.1. Hospital pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Retail Pharmacy
    • 7.4.1. Retail Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Opioids Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Opioids Market by Region: Key Takeaways
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. Saudi Arabia
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Market Participant Categorization
    • 9.2.1. Purdue Pharma L.P.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Johnson & Johnson Services, Inc.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Hikma Pharmaceuticals PLC
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Pfizer Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. AbbVie Inc.
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Sanofi
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Sun Pharmaceutical Industries Ltd
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Grunenthal
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Merck & Co., Inc.
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America opioids market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America opioids market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 5 North America opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America opioids market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. opioids market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. opioids market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 10 U.S. opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada opioids market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada opioids market, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 14 Canada opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe opioids market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe opioids market, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 18 Europe opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Europe opioids market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany opioids market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany opioids market, by application, 2018 - 2030 (USD Million)
  • Table 22 Germany opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 23 Germany opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 UK opioids market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK opioids market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 27 UK opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 France opioids market, by product, 2018 - 2030 (USD Million)
  • Table 29 France opioids market, by application, 2018 - 2030 (USD Million)
  • Table 30 France opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 31 France opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Italy opioids market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy opioids market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 35 Italy opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Spain opioids market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain opioids market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 39 Spain opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 Denmark opioids market, by product, 2018 - 2030 (USD Million)
  • Table 41 Denmark opioids market, by application, 2018 - 2030 (USD Million)
  • Table 42 Denmark opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 43 Denmark opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44 Sweden opioids market, by product, 2018 - 2030 (USD Million)
  • Table 45 Sweden opioids market, by application, 2018 - 2030 (USD Million)
  • Table 46 Sweden opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 47 Sweden opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 Norway opioids market, by product, 2018 - 2030 (USD Million)
  • Table 49 Norway opioids market, by application, 2018 - 2030 (USD Million)
  • Table 50 Norway opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 51 Norway opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific opioids market, by product, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific opioids market, by application, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 55 Asia Pacific opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific opioids market, by region, 2018 - 2030 (USD Million)
  • Table 57 Japan opioids market, by product, 2018 - 2030 (USD Million)
  • Table 58 Japan opioids market, by application, 2018 - 2030 (USD Million)
  • Table 59 Japan opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 60 Japan opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 China opioids market, by product, 2018 - 2030 (USD Million)
  • Table 62 China opioids market, by application, 2018 - 2030 (USD Million)
  • Table 63 China opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 64 China opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 India opioids market, by product, 2018 - 2030 (USD Million)
  • Table 66 India opioids market, by application, 2018 - 2030 (USD Million)
  • Table 67 India opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 68 India opioids market, by distribution channel, (USD Million) 2018 - 2030
  • Table 69 Australia opioids market, by product, 2018 - 2030 (USD Million)
  • Table 70 Australia opioids market, by application, 2018 - 2030 (USD Million)
  • Table 71 Australia opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 72 Australia opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 73 Thailand opioids market, by product, 2018 - 2030 (USD Million)
  • Table 74 Thailand opioids market, by application, 2018 - 2030 (USD Million)
  • Table 75 Thailand opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 76 Thailand opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 77 South Korea opioids market, by product, 2018 - 2030 (USD Million)
  • Table 78 South Korea opioids market, by application, 2018 - 2030 (USD Million)
  • Table 79 South Korea opioids market, by route of administration, 2018 - 2030 (USD Million)
  • Table 80 South Korea opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 Latin America opioids market, by product, 2018 - 2030 (USD Million)
  • Table 82 Latin America opioids market, by application, 2018 - 2030 (USD Million)
  • Table 83 Latin America opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 84 Latin America opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 85 Latin America opioids market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil opioids market, by product, 2018 - 2030 (USD Million)
  • Table 87 Brazil opioids market, by application, 2018 - 2030 (USD Million)
  • Table 88 Brazil opioids market, by route of administration, 2018 - 2030 (USD Million)
  • Table 89 Brazil opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 90 Mexico opioids market, by product, 2018 - 2030 (USD Million)
  • Table 91 Mexico opioids market, by application, 2018 - 2030 (USD Million)
  • Table 92 Mexico opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 93 Mexico opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 94 Argentina opioids market, by product, 2018 - 2030 (USD Million)
  • Table 95 Argentina opioids market, by application, 2018 - 2030 (USD Million)
  • Table 96 Argentina opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 97 Argentina opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa opioids market, by product, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa opioids market, by application, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 101 Middle East and Africa opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa opioids market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa opioids market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa opioids market, by application, 2018 - 2030 (USD Million)
  • Table 105 South Africa opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 106 South Africa opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia opioids market, by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia opioids market, by application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 110 Saudi Arabia opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 111 UAE opioids market, by product, 2018 - 2030 (USD Million)
  • Table 112 UAE opioids market, by application, 2018 - 2030 (USD Million)
  • Table 113 UAE opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 114 UAE opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 115 Kuwait opioids market, by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait opioids market, by application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait opioids market, by route of administration, 2018 - 2030 (USD Million)
  • Table 118 Kuwait opioids market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Opioids: Market outlook
  • Fig. 9 Opioids: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Opioids market driver impact
  • Fig. 15 Opioids market restraint impact
  • Fig. 16 Opioids market strategic initiatives analysis
  • Fig. 17 Opioids market: Product movement analysis
  • Fig. 18 Opioids market: Product outlook and key takeaways
  • Fig. 19 IR/Short acting opioids market estimates and forecasts, 2018 - 2030
  • Fig. 20 ER/Long acting opioids market estimates and forecasts, 2018 - 2030
  • Fig. 21 Opioids market: Application movement analysis
  • Fig. 22 Opioids market: Application outlook and key takeaways
  • Fig. 23 Pain relief market estimates and forecasts, 2018 - 2030
  • Fig. 24 Anesthesia market estimates and forecasts, 2018 - 2030
  • Fig. 25 Cough suppression market estimates and forecasts, 2018 - 2030
  • Fig. 26 Diarrhea suppression market estimates and forecasts, 2018 - 2030
  • Fig. 27 De-addiction market estimates and forecasts, 2018 - 2030
  • Fig. 28 Opioids market: Route of administration movement analysis
  • Fig. 29 Opioids market: Route of administration outlook and key takeaways
  • Fig. 30 Oral market estimates and forecasts, 2018 - 2030
  • Fig. 31 Injectable market estimates and forecasts, 2018 - 2030
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030
  • Fig. 33 Opioids market: Distribution channel movement analysis
  • Fig. 34 Opioids market: Distribution channel outlook and key takeaways
  • Fig. 35 Hospital pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Retail pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030
  • Fig. 38 Global opioids market: Regional movement analysis
  • Fig. 39 Global opioids market: Regional outlook and key takeaways
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 42 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030
  • Fig. 45 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 46 France market estimates and forecasts, 2018 - 2030
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 48 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 51 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 53 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 54 China market estimates and forecasts, 2018 - 2030
  • Fig. 55 India market estimates and forecasts, 2018 - 2030
  • Fig. 56 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 62 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 63 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 64 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 65 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 66 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030